Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2011-04-20 | Timothy P. Walbert has been a director since November of 2010. ... The Compensation Committee, currently consisting of Messrs. Bowes, Van Ness, Walbert and Wyszomierski... The Nominating & Governance Committee, currently consisting of Messrs. Bowes (Chairman), Hutt, Van Ness and Walbert. |
| 2012-04-11 | Timothy P. Walbert has been a director since November of 2010. ... The Compensation Committee, currently consisting of Messrs. Bowes (Chairman), Van Ness, Walbert and Wyszomierski ... The Nominating & Governance Committee, currently consisting of Messrs. Bowes (Chairman), Hutt, Van Ness and Walbert ... The table below sets forth the 2011 compensation for members of the Board who were non-employee directors at any time during 2011. ... Timothy P. Walbert total compensation $115,493. |
| 2013-04-11 | Timothy P. Walbert has been a director since November of 2010. |
| 2014-04-11 | Timothy P. Walbert has been a director since November of 2010. Mr. Walbert is Chairman, President and Chief Executive Officer of Horizon Pharma. |
| 2015-04-10 | Timothy P. Walbert has been a director since November of 2010. Mr. Walbert is Chairman, President and Chief Executive Officer of Horizon Pharma. |
| 2016-04-08 | Timothy P. Walbert has been a director since November of 2010. Mr. Walbert has served as president and chief executive officer since June 2008, and as chairman since March 2010, of Horizon Pharma plc, a publicly traded biopharmaceutical company focused on orphan, primary care and specialty medicines. |
| 2016-09-12 | Timothy P. Walbert is listed as a director with beneficial ownership in the proxy statement on pages 13-14. |
Data sourced from SEC filings. Last updated: 2025-10-12